From Nasdaq: 2025-05-04 23:21:00

Vertex Pharmaceuticals (NASDAQ:VRTX) will report earnings on May 5, 2025. Historical data shows a positive one-day return in 58% of cases, with a median return of 3.0%. This upcoming report is estimated to show $4.29 EPS on $2.86B sales, compared to last year’s $4.76 EPS on $2.69B sales.

Market reaction to earnings will depend on actual results compared to consensus. Traders can use historical data to inform strategies, such as analyzing the probability of positive returns or correlating post-earnings returns with medium-term performance. VRTX has a market cap of $130B, $11B revenue, $4.4B operating profits, and $-536M net income.

Vertex Pharmaceuticals has seen positive one-day returns in 58% of cases over the past five years. The median positive return is 3.0%, while the median negative return is -3.1%. Understanding correlations between short-term and medium-term post-earnings returns can inform trading strategies. The Trefis High Quality portfolio offers an alternative for lower volatility.

Traders can analyze the correlation between short-term and medium-term post-earnings returns to inform trading strategies. The Trefis RV strategy has outperformed all-cap stocks benchmarks, while the High Quality portfolio has generated over 91% returns since inception. Consider these options for potential upside with lower volatility than individual stocks like Vertex Pharmaceuticals.



Read more at Nasdaq: How Will Vertex Pharmaceuticals Stock React To Its Upcoming Earnings?